Abstract:SESSION TITLE: Late-breaking Abstract Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: October 18-21, 2020 PURPOSE: There are no published studies concerning the clinical characteristics of patients with coronavirus disease 2019 (COVID-19) resident in high altitude. We aim to analyze the unique cohort and investigated the relationship among the patients resident in different altitude areas of Sichuan province, China. METHODS: We retrospectively reviewed the medical data including clinical features, imaging findings, laboratory characteristics and received treatment of confirmed cases of COVID-19 with WHO interim guidance in Sichuan province from Jan 12th to March 12th, 2020. Outcomes were also compared between patients from high-altitude and non-high-altitude area. RESULTS: 537 patients were included in this study, 78 were from high-altitude area and 459 from non-high-altitude area. The high-altitude area group was less likely had a clear travel history of Wuhan (9.0% vs. 64.3%, p<0.001) or contact with people from Wuhan (10.3% vs. 25.5%, p=0.003) within recent two weeks, but more likely contact with people infected of COVID-19 never been to Wuhan (60.3% vs. 3.3%, p<0.001) or of unknown origin (20.5% vs.7.0%, p<0.001). The high-altitude area group was more likely asymptomatic before admission (50.6% vs. 8.7%, p<0.001). Less patients with cough, sputum production and fever in the cohort comparing with those in non-high-altitude area. Lower body temperature, slower heart rate, and lower blood pressure relatively on admission were also found in high-altitude patients as well. The period from onset of illness to visit was 3 days (range, 1-7 days) and to diagnosis was 4 days (range,1-7 days), which were both significantly shorter in the group of high-altitude area. The patients from high-altitude had significantly higher lymphocyte count, lower platelet count and lower level of erythrocyte sedimentation rate (p all＜0.05). Less patients with abnormally elevated C-reactive protein were also observed in high-altitude group (p＜0.05). The most common patterns seen in these population on chest CT were bilateral distribution, ground-glass opacity, and consolidation and nodules. Multifocal distribution and consolidation were noted and showed significant in high-altitude patients. The proportion of patients with mild illness was significantly higher in the high-altitude area group (16[20.5%] vs. 33[7.2%], p<0.001). More likely to receiving antiviral and glucocorticoid therapies and less likely to receiving antibiotic drugs were shown in the patients in high-altitude area. Multivariate logistic analysis indicated that age, gender, diabetes and recent travel history of Wuhan were predictors of severe pneumonia. CONCLUSIONS: The disease severity of COVID-19 in Sichuan province was milder than Wuhan. More patients in high-altitude area were asymptomatic. It could owe to the active prevention, early detection and timely treatment. CLINICAL IMPLICATIONS: Active prevention, early detection and timely treatment is critical in COVID-19. DISCLOSURES: No relevant relationships by Aamer Chughtai, source=Web Response No relevant relationships by Lu Guo, source=Admin input no disclosure on file for Caiyu Jiang; no disclosure on file for Xiayin Peng; no disclosure on file for Hong Pu; no disclosure on file for Weiwei Qiang; no disclosure on file for Yang Yang

Clinical Characteristics of High-Altitude Interstitial Lung Disease: a Two-Center, Retrospective, Observational Study

[The clinical characteristics of acute severe high-altitude diseases in indigenous Tibetans]

Clinical and Radiological Features of COPD Patients Living at ≥3000 M above Sea Level in the Tibet Plateau

CLINICAL CHARACTERISTICS OF 537 CASES OF COVID-19 IN DIFFERENT ALTITUDE OF SICHUAN PROVINCE, CHINA: A RETROSPECTIVE STUDY

Incidence and risk factors of severe acute high-altitude illness in healthy adults first entering the northern Tibetan Plateau of over 5,000 m

Clinical characteristics and laboratory features of COVID-19 in high altitude areas: A retrospective cohort study

Clinical and Etiological Characteristics of Community-Acquired Pneumonia at High Altitudes in Tibet, China

[Clinical characteristics of acute pulmonary embolism at different altitudes in plateau areas]

Clinicopathological characteristics and features of molecular subtypes of breast cancer at high altitudes

Diagnostic value of CT in patients with stable chronic obstructive pulmonary disease at high altitude: Observational study

Prevalence and Risk Factors for COPD at High Altitude: A Large Cross-Sectional Survey of Subjects Living Between 2,100–4,700 m Above Sea Level

Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 1,044 Chinese Patients

Abstract TP267: Cerebral Venous Thrombosis at High Altitude: A Comparison of Patients From Plateau and Plain in China

Analysis of clinical characteristics of patients with pulmonary hypertension in Chaya County, Chamdo, Tibet

Cerebral venous thrombosis at high altitude: more severe symptoms and specific predisposing factors than plain areas

Comparison of the lower limit of normal to the fixed ratio method for the diagnosis of airflow obstruction at high altitudes: a large cross-sectional survey of subjects living between 3000-4700 m above sea level

Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes

Clinical and Imaging Features of COVID-19 Patients: Analysis of Data from High-Altitude Areas

Research advances in pathogenesis and prophylactic measures of acute high altitude illness

Clinical Features and Determinants of Disease Severity of Immune Checkpoint Inhibitor-Related Pneumonitis: A Retrospective Study

More severe initial manifestations and worse short-term functional outcome of intracerebral hemorrhage in the plateau than in the plain